Bahl & Gaynor’s Marrone Bio Innovations, Inc. MBII Stock Holding History

Bahl & Gaynor’s Portfolio MBII Stock Details MBII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-10,000	Closed	-$12K	–	329
2022 Q2	$12K	Hold	10,000	–	–	﹤0.01%	323
2022 Q1	$11K	Hold	10,000	–	–	﹤0.01%	337
2021 Q4	$7K	Hold	10,000	–	–	﹤0.01%	338
2021 Q3	$9K	Hold	10,000	–	–	﹤0.01%	337
2021 Q2	$17K	Buy	+10,000	New	+$16.7K	﹤0.01%	341

Bahl & Gaynor's MBII Position: Q3 2022 in Review

Bahl & Gaynor sold out of Marrone Bio Innovations, Inc. (MBII) in Q3 2022, closing a stake of 10,000 shares — an estimated $12K sold.

Bahl & Gaynor first reported a position in MBII in Q2 2021 and held it in 5 quarters. The position peaked at $17K in Q2 2021. 0 funds tracked by Wall St. Rank hold MBII as of Q3 2022.

Bahl & Gaynor reported no remaining Marrone Bio Innovations, Inc. position as of Q3 2022 after selling out during the quarter.
Bahl & Gaynor sold 10,000 Marrone Bio Innovations, Inc. shares in Q3 2022, an estimated $12K.
Bahl & Gaynor first reported a position in Marrone Bio Innovations, Inc. in Q2 2021 and held it in 5 quarters.
Bahl & Gaynor's Marrone Bio Innovations, Inc. position peaked at $17K in Q2 2021.
0 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q3 2022.

Based on Bahl & Gaynor's 13F filing for Q3 2022, filed 14 Nov 2022.